A modification of Broughton's method for the determination of barbiturate in biological fluids is described which reduces the time of analysis to 15 min. and requires only 2 ml blood. Minimal reagents and apparatus are required. The method has been standardised and is accurate to barbiturate concentrations as low as 0.5 mg(lOO ml blood.
For a patient suffering from drug overdosage, speed and accuracy are desirable and often the barbiturate determination, requiring 45 or 50 min., is the last analysis to be completed.
In laboratories not equipped for gas chromatography, the method in most common use is that of Goldbaum (1952) which was modified by Broughton in 1956.
Broughton's method consists of extracting whole blood, urine or gastric contents thrice with chloroform, the extracts being filtered through paper into a separating funnel, as are also the filter paper washings. The total extract is shaken with sodium hydroxide, 0.45 mol/I, which is separated and clarified by centrifugation. Two separate and equal volumes of the alkaline extract are diluted, one with an equal volume of sodium hydroxide, 0.45 mol/l, and the other with a boric acid: potassium chloride buffer solution giving two solutions of pH 13.4 and 10.0 respectively. The difference in optical density at 260 nm (0.0'260) of these two solutions, when read against appropriate blanks, and when multiplied by an appropriate calibration factor, gives the value for the barbiturate level in the test solution. Partial identification of the type of barbiturate present is obtained by heating the alkaline (pH 13.4) barbiturate solution at 100"C for 15 min. and comparing the ratio 0.0'2611 before and after hydrolysis.
EXPERIMENTAL
In the simplification and standardisation of this method a number of alterations were made.
I. The number of extractions from blood to chloroform was reduced from three to one. 2. The use of separating funnels was discarded in favour of stoppered flasks.
A mechanical shaker incorporating a time
switch was used for the extraction process thus reducing and standardising the time required at this stage. 4. The volume of specimen and extractants was reduced to give greater ease of handling and economy of material.
5. As Broughton emphasised, the absorption spectrum over the range 225-270 nm must be scanned to ensure the fulfilment of typical barbiturate wavelength and isobestic criteria. This is most conveniently done by a recording spectrophotometer. 6. The use of 1.0 ml semi-micro silica cuvettes of I ern light path reduced the volume of final alkaline extract required.
Volume of sodium hydroxide required
This was determined by the volume required to fill the cuvette, viz 1.0 ml, and it was calculated that a volume of 4.0 ml sodium hydroxide, 0.45 mol/l, would be sufficient to give duplicate determinations of the pH 13.4 and pH 10.0 solutions and also for alkaline hydrolysis.
Volume of chloroform required
This depended on the volume ratio of chloroform extract to sodium hydroxide. A solution of 0.5 mg barbitone in 100 ml chloroform was prepared and extracted for 3 min. using mechanical shaking, the barbitone was extracted from various volumes of this chloroform solution into 4 ml volumes of sodium hydroxide. The results are recorded in Table I . The results are given in Tables 3 and 4 .
Extraction of barbiturate from chloroform to sodium hydroxide
The conditions for this extraction were those previously discussed, namely a 3 min. extraction with intimate phase mixing and avoidance of emulsification. To obtain a clear supernatant sodium hydroxide extract, the contents of the flask are transferred to a 110 x 16 mm tube and centrifuged at 2000 r.p.m. for 3 min.
From Tables 3 and 4 , it can be seen that prolonged and very vigorous shaking during extration, results in smaller .10.0"60 values and lower chloroform extract volume recoveries, probably due to a tendency to emulsification.
It was decided to adopt a 3 min. extraction time as standard. The degree of shaking was established by adjusting the shaker to give intimate mixing of the aqueous and organic phases while avoiding emulsification by over vigorous shaking. This is not difficult to do as there is a reasonable adjustment tolerance between these two degrees of mixing. where the blood CHCI: 1 ratios were identical, there was a 10% difference in [',,0.0',80' To study this more closely and at the same time investigate the sensitivity of the method over a wider range, all of the above six determinations were repeated on a series of barbiturate concentrations from 0.5-10.0 mgjlOO ml whole blood. The results are given in graphical form in Figure I .
In the case of 4 ml blood and 10 ml CHCI 3 the non linearity was due to the formation of emulsions and there was a similar tendency with 3 ml blood and 10 ml CHCI 3 • It seemed therefore, that 2 ml blood extracted by 10 ml CHCI 3 and the latter in turn extracted by 4 ml sodium hydroxide constituted the basis of a satisfactory method. A series of extractions was carried out from 2, 3 and 4 ml samples of a 5 mg barbitone/IOO ml, heparinised, whole blood stock into IO and 20 ml chloroform. Each chloroform extract was then Table 4 . Vigour ofextraction shaken with 4 ml NaOH, 0.45 mol/I, and the .10.D. at 260 nm determined in each case. The results are recorded in Table 2 .
From these figures it is obvious that extraction of barbiturate into a fixed volume of 4 ml sodium hydroxide from volumes of chloroform over the range 10-40 ml is acceptable in all cases. The limiting factors, therefore, would appear to be the original volume of blood used and general handling characteristics.
Time and degree of shaking during extraction
Using the volumes of blood and extractants established above, the time and degree of shaking for extraction were studied.
Factors, standard deviations and recoveries
Following the procedure decided upon, the [',,0.0'280 in a series of blood samples containing 10 mgjlOO ml of the following barbiturates were 2",1. determined :-phenobarbitone, barbitone, butobarbitone, amylobarbitone, cyclobarbitone, quinalbarbitone and pentobarbitone. At the same time, 10 mg/IOO ml solutions of these barbitones in 0.45 mol/I NaOH were prepared and by treating these in the same way as the final sodium hydroxide extracts, figures for the absolute 10 mgt 100 ml concentrations in terms of ,1\.0.0'260 were obtained. More than 50 determinations were carried out in each case and, from the results obtained, the histograms shown in Fig. 2 were constructed. Calibration factors were calculated to convert the values obtained in blood to absolute levels. These factors are listed in Table 5 as are the standard deviations of the ,1\.0.0'260 values for the various barbiturates and the percentage recoveries for this method.
Identification of type of barbitone
Adhering to the alkaline hydrolysis principle as described by Broughton, the following procedure was followed.
2 ml sodium hydroxide extract in a loosely stoppered, 10 ml graduated tube, is placed in boiling water for exactly 15 min., cooled and the volume adjusted, if necessary, to the original 2 ml with distilled water. The hydrolysed extract is then treated in a similar fashion to the test solution and the ,1\.0.0'260 determined. The ratio (R) of ,1\.0.0'260 hydrolysed to 6,0.0'260 test is multiplied by 100 and from this figure an indication of the length of action is obtained as shown in Table 6 .
Interfering drugs
Sulphonamides, which interfere, may be removed by washing the chloroform extract with 0.5 mol/I, pH 7.4, phosphate buffer. This wash removes about 15% of the barbiturate present and a correction should be made for this. 
Pentobarbitone
Ooriden and Megamide interference is overcome by leaving the sodium hydroxide extract for 30-60 min. before reading as both these drugs are alkali labile.
Phenytoin interference is not a serious problem, a concentration of 40 /-Lg/ml reducing the aparent barbiturate by 10 %.
Carbrital (pentobarbitone and carbromal) gave a rather distorted barbiturate pattern which was however, typical and recognisable for this drug and allowed approximate barbiturate concentrations to be assessed. No interference from salicylate up to 50 mg/lOO ml blood was found. No interference from Mandrax was found.
Phase separating paper gave marked interference and must on no account be used to separate the aqueous and organic phases.
PROPOSED METHOD

